Manette Niu, MD

Acting Branch Chief, Division of Pharmacovigilance, FDA CBER OBPV

CBER official who received Dr. Szarfman's RGPS analyses in 2021 and told her CBER could not collaborate with her on the project.

Timeline appearances (11)

Quotes (3)

  • "[t]he best person to ask would be Ana [Szarfman] as she has close ties with Bill DuMouchel."
    Niu told colleagues she would forward DuMouchel's data mining results and identified Szarfman as the right person to involve. · 2021-04-15 view in /quotes/ →
  • "[w]hile we are aware that CDER is using the vaccine data to explore new calculations and various deviations of analysis parameters in disproportionality analysis, I haven't been, and are unable to, work as a collaborator with you on this project due to our higher priority work, and because this sort of statistical development work falls outside of my area of expertise."
    Niu rebuffed Szarfman, declining to collaborate on the new methodology with language drafted by Zinderman. · 2021-04-25 view in /quotes/ →
  • "[n]o, I haven't requested anything from Ana. I am only passively passing on her data mining runs when she sends them to me."
    Niu replied to Menschik distancing herself from Szarfman after Menschik asked whether she had been working with her on data mining. · 2021-04-29 view in /quotes/ →